Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Health and Productivity as a Business Strategy: A Multiemployer Study

This study, sponsored by the National Pharmaceutical Council and published in the April issue of the Journal of Occupational and Environmental Medicine (JOEM), explored methodological refinements in measuring health-related lost productivity and assessed the business implications of a full-cost approach to managing health. After measuring productivity loss among 10 employers with 51,648 employee respondents and analyzing 1.13 million medical and pharmacy claims, researchers found that health-related productivity costs significantly exceed medical and pharmacy costs - on average 2.3 to 1. In addition, depression, obesity, arthritis, back and neck pain and anxiety drive the majority of costs when looking at both productivity and medical and pharmacy costs. The study also found presenteeism -- when employees with health conditions are present at their jobs but are unable to perform at full capacity -- to be a bigger drain on productivity than absenteeism.

Due to copyright issues, this study is only available through the JOEM website.

View the press release with further details, and watch the video with Dr. Ron Loeppke, executive vice president of Alere Inc., and Dr. Pamela Hymel, corporate medical director of integrated health at Cisco Systems, about the study's findings.

Newsletter Volume

E.V.I.dently: April 2016

MessageValue Assessment Through a Broader, Patient-Focused LensNPC has developed “Guiding Practices for Patient-Centered Value Assessment” to help...
Blog Post

Bundled Payments: Opportunities and Challenges

As use of bundled payments increases, how do health system stakeholders minimize the risk of unintended consequences and maximize chances this...
Newsletter Volume

E.V.I.dently October 2015

MessageWhat’s the Fuss About Evidence From Clinical Experience? Here’s Why It MattersAt a health care forum in Washington, DC, earlier this month,...
Blog Post

#TBT: Value-Based Insurance Design & New Medicare Advantage Model

As part of our Throwback Thursday blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research...
Press Release

New Study Examines Risk-Sharing Agreements Between Pharmaceutical Manufacturers and Payers

(Washington, DC, September 16, 2015)—A newly released study has found that risk-sharing agreements (RSAs) between pharmaceutical companies and health...
Press Release

Specialty Medications: Shifting the Focus From “How Much” We Spend to “How Well” We Spend

Washington, DC, June 9, 2014—As health care decision-makers grapple with how to ensure access to specialty medications, the University of Michigan...
Press Release

NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer

WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (...
Press Release

Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity

(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...
Commentary and Testimony Page

Chain Drug Review – Commentary: “Health Care Outlook for 2015”

This commentary was originally published in the January 5, 2015 issue of Chain Drug Review.By: Dan Leonard, President, National Pharmaceutical...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
Commentary and Testimony Page

The Risks of Standardized Health Care

Think about the last time you visited a medical office. Even at a specialist’s office, chances are that each person waiting for his or her name to be...
Commentary and Testimony Page

High Stakes for Setting Research Standards

What is the cost of poorly designed research? In the comparative effectiveness arena, faulty studies could mean that consumers may make important...
YouTube Videos

Access to Specialty Medications & Value-Based Insurance Design

Specialty medications have been making health care headlines because of their effectiveness and higher costs. How can we ensure that patients will...
YouTube Videos

Shifting the Focus From "How Much" to "How Well" We Spend Our Health Care Dollars

A. Mark Fendrick, MD, director of the Center for Value-Based Insurance design at the University of Michigan, highlights the key findings from a...
YouTube Videos

Engaging Consumers in Today's Changing Health Care Payment and Delivery Environment

The current health care delivery system is evolving from a fee-for-service system to one that is performance-based. How does this shift impact...
YouTube Videos

Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design

Access to specialty medications is a particularly pressing issue for many people who rely on these treatments for conditions that are often very...
Blog Post

Bundled Payments: Opportunities and Challenges

As use of bundled payments increases, how do health system stakeholders minimize the risk of unintended consequences and maximize chances this...
Blog Post

#TBT: Value-Based Insurance Design & New Medicare Advantage Model

As part of our Throwback Thursday blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research...
Blog Post

New Models Like V-BID Driving Value-Based Health Care

From accountable care organizations and bundled payments to patient-centered medical homes and value-based insurance design (V-BID), new delivery and...
Blog Post

The Value of Value-Based Insurance Design

The ongoing shift in our health care payment and delivery system from volume-based to value-based has generated a lot of attention, especially with...
  •  
  • 1 of 38
  • >